This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovations of Scott Freeze: Pioneering Heteroaryl Compounds
Introduction: Scott Freeze is an innovative inventor based in Boston, MA, who has made significant contributions to the field of medicinal chemistry. With a keen focus on developing compounds that can inhibit specific enzymes involved in various diseases, Scott has secured a patent that demonstrates his commitment to advancing medical science.
Latest Patents: Scott Freeze holds a notable patent for "Heteroaryl compounds useful as inhibitors of SUMO activating enzyme." The patent describes a range of chemical entities characterized by the formula (I) or their pharmaceutically acceptable salts. The disclosed compounds are designed to act as inhibitors of the Sumo Activating Enzyme (SAE). These chemical entities are poised to provide therapeutic benefits in treating proliferative, inflammatory, cardiovascular, and neurodegenerative diseases or disorders.
Career Highlights: Scott Freeze's career is highlighted by his dedication to research and development, particularly in the realm of drug discovery. His work at Millennium Pharmaceuticals Limited emphasizes the importance of innovative solutions in addressing complex medical challenges. With one patented invention to his name, Scott demonstrates the impact that focused research and collaboration can have in the pharmaceutical industry.
Collaborations: Throughout his professional journey, Scott has collaborated with talented coworkers such as Matthew O Duffey and Dylan Bradley England. These partnerships have contributed to a dynamic environment focused on fostering innovation and enhancing the development of groundbreaking therapies.
Conclusion: Scott Freeze's work as an inventor exemplifies the spirit of innovation in the pharmaceutical industry. His patent for Heteroaryl compounds highlights the potential for novel treatments aimed at various diseases, showcasing how dedicated research and collaboration can lead to meaningful advancements in healthcare. As Scott continues his journey in the field, his contributions are likely to inspire future innovations that enhance the quality of life for many.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile